Core Viewpoint - Rosen Law Firm is reminding investors who purchased Eos Energy Enterprises, Inc. securities between November 5, 2025, and February 26, 2026, of the May 5, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Eos Energy securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is May 5, 2026, with the lead plaintiff acting on behalf of other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4]. Group 3: Case Allegations - The lawsuit alleges that Eos Energy made false or misleading statements and failed to disclose critical information regarding its production capabilities and operational issues [5]. - Specific claims include Eos Energy's inability to meet production ramp-up and capacity utilization targets, excessive battery line downtime, and delays in achieving quality targets for automated production [5]. - The lawsuit asserts that these issues led to materially misleading statements about Eos Energy's business and operations, resulting in investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Alight, Inc. common stock during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and growth claims [1][5]. Group 1: Lawsuit Details - The class action lawsuit is filed for purchasers of Alight common stock between November 12, 2024, and February 18, 2026, inclusive [1]. - The lawsuit alleges that Alight made false or misleading statements regarding its growth potential and financial stability, failing to disclose its inability to maintain promised dividends [5]. - Throughout the Class Period, Alight reportedly announced disappointing results and reduced projections, which led to investor damages when the true state of the company was revealed [5]. Group 2: Participation Information - Investors who purchased Alight common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by May 15, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, having achieved significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its success in securities class action settlements, ranking highly in the industry since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Driven Brands Holdings Inc. between May 9, 2023, and February 24, 2026, about the upcoming lead plaintiff deadline on May 8, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Driven Brands common stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the court by May 8, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action settlements [4]. Group 3: Case Specifics - The lawsuit alleges that Driven Brands made false or misleading statements regarding its financial condition and internal controls, leading to inaccurate financial reports filed with the SEC from May 9, 2023, to November 5, 2025 [5]. - Specific issues cited include an unreconciled cash balance from 2023 that resulted in overstated revenue and cash for 2023 and 2024, as well as understated operating expenses during the same period [5].

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Oracle Corporation (NYSE: ORCL) between June 12, 2025, and December 16, 2025, inclusive (the “Class Period”), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If you purchased Oracle common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Elauwit Connection, Inc. due to allegations of materially misleading business information issued to the investing public [1] Group 1: Legal Action and Investor Rights - Shareholders who purchased Elauwit securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2] - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [2] Group 2: Company Financial Reporting Issues - On February 27, 2026, Elauwit filed a Current Report with the SEC, announcing non-reliance on previously issued interim financial statements due to an error in revenue recognition related to a network construction project [3] - The stock price of Elauwit fell by $0.52 per share, or 6.8%, closing at $7.12 per share following the announcement [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in securities class action settlements [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased REGENXBIO, Inc. securities between February 9, 2022, and January 27, 2026, of the April 14, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought REGENXBIO securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2026 [2]. - The lead plaintiff acts on behalf of other class members in directing the litigation [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Case Specifics - The lawsuit alleges that defendants provided misleading information regarding REGENXBIO's RGX-111 gene therapy for treating severe Mucopolysaccharidosis Type I, while concealing material adverse facts about the trial's efficacy and safety [4]. - Defendants made positive assertions about RGX-111's future trial success based on favorable biomarker and safety data, which were later contradicted by the actual trial results, leading to investor damages [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased GSI Technology securities, with no out-of-pocket fees through a contingency fee arrangement [2]. - A significant drop in GSI Technology's stock price occurred after allegations surfaced regarding the company's chip performance, leading to a decline of $1.08 per share, or 14.2%, closing at $6.52 per share [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has consistently been recognized for its success in this field [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Picard Medical, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Picard Medical securities between September 2, 2025, and October 31, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 13, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations during the class period [5]. - Specific allegations include involvement in a fraudulent stock promotion scheme, insider trading through offshore accounts, and omission of critical information regarding stock price manipulation [5].

Core Viewpoint - A class action lawsuit has been filed against monday.com Ltd. for allegedly making false statements regarding its revenue growth and expansion outlook during the specified class period from September 17, 2025, to February 6, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants concealed material adverse facts about monday.com's decelerating growth, reduced expansion momentum, and extended sales cycles, which led to investor damages when the true information became public [5]. - Investors who purchased common stock during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by May 11, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Trip.com Group Limited securities between April 30, 2024, and January 13, 2026, of the May 11, 2026, deadline to become lead plaintiffs in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Trip.com securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by May 11, 2026, to serve as lead plaintiffs, representing other class members in the litigation [3]. - The lawsuit alleges that defendants made false or misleading statements and failed to disclose regulatory risks associated with Trip.com's monopolistic business practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 alone [4].